DASH vs SGMT · P/E 76, rev $13.72B vs rev $2.0M
DoorDash, Inc. Class A Common Stock (DASH) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the DASH and SGMT stock pages for the full models.
Not investment advice.